Ophthalmology device startup pulls in $8M; Analysts: GI endoscopy market will reach $2.5B by 2016;

 @FierceMedDev: Siemens buys an ultrasound imaging startup - Penrith Corp. More | Follow @FierceMedDev

 @MarkHFierce: ForSight Vision 5., a ophthalmology device startup, raised $8 million. Via MedCity NewsMore | Follow @MarkHFierce

 @DamianFierce: Another recall from Covidien, this time over its Duet tissue-reinforcement device, tied to three deaths. More | Follow @DamianFierce

> BSD Medical ($BSDM) gained marketing approval in Russia to market its hypothermia treatment devices. Release

> More than 123 million medical device products were recalled in the 2012 second quarter, according to the quarterly ExpertRecall index. Item

> The U.S. gastrointestinal endoscopy market should reach $2.5 billion by 2016, driven by an aging population and greater colorectal cancer screening, Millennium Research Group concludes. Release

> Toshiba America Medical systems secured FDA clearance for its new Vantage Titan 1.5T MR systems. Release

> NanoLogix will start selling new tuberculosis diagnostic tests under FDA 510(k)-exempt status. Release

Biotech News

 @FierceBiotech: Boehringer sets Sept. launch date for pharma's first social game on Facebook. Article | Follow @FierceBiotech

 @JohnCFierce: SEC charges biotech exec with insider trading - first Bristol-Myers Squibb, now Array. Another one of these and I'm calling it a trend. More | Follow @JohnCFierce

 @RyanMFierce: Merck's Varivax slashes U.S. chickenpox cases. More | Follow @RyanMFierce

> Analysts: Roche's armed antibody will help drive breast cancer drug sales. Story

> Gilead writes off $11M gamble after PAH drug flunks PhII. News

> Analysts show why orphan drug development is going gangbusters. Report

Pharma News

 @FiercePharma: Check out the soon-to-be-launched Facebook game from Boehringer, if you haven't already. More | Follow @FiercePharma

> Indian court puts off Novartis patent hearing to Sept. 11. Article

> Ex-rep claims Abbott pushed TriCor off-label. News

> Cipla, Aspen eye joint excursion in Australia. More

Biomarkers News

> Gene signature picks out radiation-sensitive cancers. Story

> Blood biomarkers could pinpoint common kidney disease. More

> It's all relative: Protein marks lower dementia risk in siblings. Item

> Biomarker signatures tag liver transplant failure. Article

Drug Delivery News

> Tobacco money funds NanoJacket cancer drug delivery. News

> Ocular Therapeutix eyes punctal delivery in Phase II. Story

> Protein capsules fight a toothy battle. Article

> DNA origami delivers doxorubicin, downs resistance. More

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.